Drug class
Benzimidazole anthelmintic; parasite microtubule inhibitor
Mechanism of action
Binds parasite beta-tubulin and inhibits microtubule polymerisation, disrupting glucose uptake and intracellular transport and leading to energy depletion and parasite death.
General use cases
- Treatment of intestinal helminth infections in countries where flubendazole products are authorised, including selected nematode infections; indications, age criteria and formulation are jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
